Vlad Vitoc insider trades: MAIA Biotechnology (MAIA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vlad reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | MAIA | ↑ Buy | 73,000 | $1.37 | $100K | Direct | Sep 15, 2026 (1d) |
| Jun 1, 2026 | MAIA | ↑ Buy | 72,700 | $1.39 | $101K | Direct | Jun 2, 2026 (1d) |
| Nov 28, 2025 | MAIA | ↑ Buy | 72,000 | $1.11 | $80K | Direct | Dec 1, 2025 (3d) |
| Nov 25, 2025 | MAIA | ↑ Buy | 10,500 | $0.97 | $10K | Direct | Nov 28, 2025 (3d) |
| Nov 24, 2025 | MAIA | ↑ Buy | 11,800 | $0.98 | $12K | Direct | Nov 25, 2025 (1d) |
| Apr 28, 2023 | MAIA | ↑ Buy10b5-1 | 4,000 | $2.50 | $10K | Direct | May 1, 2023 (3d) |
| Apr 4, 2023 | MAIA | ↑ Buy10b5-1 | 2,300 | $3.52 | $8K | Direct | Apr 5, 2023 (1d) |
| Mar 31, 2023 | MAIA | ↑ Buy10b5-1 | 1,700 | $3.46 | $6K | Direct | Apr 3, 2023 (3d) |
| Mar 8, 2023 | MAIA | ↑ Buy10b5-1 | 1,581 | $4.21 | $7K | Direct | Mar 9, 2023 (1d) |
| Mar 7, 2023 | MAIA | ↑ Buy10b5-1 | 1,983 | $4.24 | $8K | Direct | Mar 8, 2023 (1d) |
| Mar 3, 2023 | MAIA | ↑ Buy10b5-1 | 2,443 | $4.47 | $11K | Direct | Mar 6, 2023 (3d) |
| Mar 1, 2023 | MAIA | ↑ Buy10b5-1 | 1,557 | $4.49 | $7K | Direct | Mar 2, 2023 (1d) |
| Feb 17, 2023 | MAIA | ↑ Buy10b5-1 | 73 | $4.25 | $310 | Direct | Feb 22, 2023 (5d) |
| Feb 16, 2023 | MAIA | ↑ Buy10b5-1 | 20 | $4.25 | $85 | Direct | Feb 17, 2023 (1d) |
| Feb 10, 2023 | MAIA | ↑ Buy10b5-1 | 343 | $4.24 | $1K | Direct | Feb 14, 2023 (4d) |
| Jan 4, 2023 | MAIA | ↑ Buy10b5-1 | 1,266 | $3.68 | $5K | Direct | Jan 6, 2023 (2d) |
| Jan 3, 2023 | MAIA | ↑ Buy10b5-1 | 2,734 | $3.62 | $10K | Direct | Jan 4, 2023 (1d) |
| Aug 1, 2022 | MAIA | ↑ Buy | 6,000 | $5.00 | $30K | Direct | Aug 2, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MAIA insiders
Open-market trades in the last 12 months
About Vlad Vitoc's insider trades
Vlad Vitoc is Chief Executive Officer at MAIA Biotechnology (MAIA). Since Aug 1, 2022, Vlad has reported 18 open-market purchases worth $406K and no sales on SEC Form 4. In the last 12 months: 5 buys ($302K).
Their filings also include grants and awards (9 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MAIA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.